SYNOPSIS A study of the prognostic value of serum fibrin/fibrinogen degradation products (FDP) in 137 consecutive patients with acute myocardial infarction showed a positive correlation between high FDP levels and poor prognosis. Both the frequency of complications and the mortality were related to increased levels of FDP, the highest of which were found between the fourth and eighth days after infarction.
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In recent years the estimation of serum fibrin/ fibrinogen degradation products (FDP) after myocardial infarction has attracted the attention of many physicians and biochemists. Baele et al (1972) and Simmons et al (1973) all report a poor prognosis in patients with high levels following the acute incident. Almer et al (1972) 
Results
On clinical grounds, the 137 patients were divided into two main groups:
Group A consists of 92 (67 %) patients who made an uneventful recovery during their stay in the hospital and have since remained well.
Group B consists of the remaining 45 (33 %) patients who either died in hospital, had complicated convalescence, or who died shortly after returning home.
All patients have been followed up from a minimum of three to a maximum of 12 months from the acute incident. Of the 45 patients in group B, 31 (69%) died in hospital, and 10 (22%) died after theirreturn home. The remaining four (9 %) each had a very stormy convalescence due to the development of major complications of myocardial infarction, but all four are still alive after at least three months follow-up. (Cash et al, 1969) and dissecting aortic aneurysm (Almer et al, 1972) . It has been observed by Simmons et al (1973a) (Baele et al, 1972; Almer et al, 1972; Simmons et al, 1973b ) that the elevated levels recorded during the first one or two weeks following myocardial infarction are related to the frequency of subsequent complications.
In 138 cases, Baele et al (1973) similarly found that the patients with a serum FDP level of more than 10 jg/ml generally have a bad prognosis, the mortality and frequency of complications being strikingly high. Baele et al (1972) and Almer et al (1972) found a sinister prognosis in 92 patients with raised serum FDP concentration within 24 and 48 hours respectively after infarction. Our findings agree with this in that patients who had a high concentration (more than 10 ,ug/ml) within 48 hours after infarction experienced a high mortality (80 %). Simmons et al (1973b) describe a poor prognosis in 55 patients, with high levels of serum FDP from five to eight days after infarction. Similarly, in our cases the highest levels in the patients of group B were found between the fourth and eighth days after infarction.
Conclusion
Although the exact mechanism leading to high levels ofserum FDP after acute myocardial infarction is not clearly established, our preliminary results confirm previous suggestions that patients with an increased level following myocardial infarction usually have a bad prognosis. Because high levels are found between the fourth and eighth days after infarction, it would seem reasonable to carry out one or two estimations of serum levels during that period. This would help in the selection of high risk patients early in their illness with a view to arranging a longer period of observation in hospital than is usual for those with a good prognosis.
Our thanks are due to Dr A. P. B. Waind, MD, FRCP, consultant physician, under whose care some of the patients were admitted, and to Mr R. N.
Nuttall, FIMLT, for technical assistance. 
